These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain. Marlier D, Mainil J, Boucraut-Baralon C, Linden A, Vindevogel H. J Comp Pathol; 2000 Apr; 122(2-3):115-22. PubMed ID: 10684680 [Abstract] [Full Text] [Related]
10. Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stability. Muller A, Silva E, Abrantes J, Esteves PJ, Ferreira PG, Carvalheira JC, Nowotny N, Thompson G. Vet Microbiol; 2010 Jan 06; 140(1-2):161-6. PubMed ID: 19709821 [Abstract] [Full Text] [Related]
11. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Barry M, Hnatiuk S, Mossman K, Lee SF, Boshkov L, McFadden G. Virology; 1997 Dec 22; 239(2):360-77. PubMed ID: 9434727 [Abstract] [Full Text] [Related]
18. Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Lalani AS, Masters J, Graham K, Liu L, Lucas A, McFadden G. Virology; 1999 Apr 10; 256(2):233-45. PubMed ID: 10191189 [Abstract] [Full Text] [Related]